|
⚲
|
| Keyboard |
| Westlake BioPartners Fund I LP
✚
|
|
|---|---|
| CIK # | 0001749591 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001749591] | |
| 4 | [0001749591] | |
| D | [0001749591] | |
| SC 13G | [0001749591] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Westlake Biopartners Fund I LP | Kyverna Therapeutics Inc | [2024-11-12] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2025-12-18 | Buy | 133,333 | $7.50 | 999,998 |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 735,984 | ||
|
Kyverna Therapeutics Inc KYTX
Series A-2 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 8,830,901 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Common Stock
|
2024-02-12 | Conversion | 3,787,940 | ||
|
Kyverna Therapeutics Inc KYTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 3,349,538 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Series A-1 Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 4,401,771 | $0.00 | |
|
Kyverna Therapeutics Inc KYTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2024-02-12 | Conversion | 4,006,624 | $0.00 |